Extended-release opioid antagonists and HIV treatment

被引：0
作者：
Lee, Joshua D. [1 ]
Kunoe, Nikolaj
机构：
[1] NYU, Sch Med, Dept Populat Hlth, New York, NY 10016 USA
来源：
LANCET HIV | 2019年 / 6卷 / 04期
关键词：
ORAL NALTREXONE; DOUBLE-BLIND; PLACEBO; OUTCOMES; IMPLANT;
D O I：
10.1016/S2352-3018(19)30040-2
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：E206 / E207
页数：2
相关论文
共 14 条
  • [1] The expanding epidemic of HIV-1 in the Russian Federation
    Beyrer, Chris
    Wirtz, Andrea L.
    O'Hara, George
    Leon, Nolwenn
    Kazatchkine, Michel
    [J]. PLOS MEDICINE, 2017, 14 (11)
  • [2] Excess mortality among opioid-using patients treated with oral naltrexone in Australia
    Degenhardt, Louisa
    Larney, Sarah
    Kimber, Jo
    Farrell, Michael
    Hall, Wayne
    [J]. DRUG AND ALCOHOL REVIEW, 2015, 34 (01) : 90 - 96
  • [3] Indivior, 2018, SUBLOCADE PRESCR INF
  • [4] Fatal and non-fatal opioid overdose in opioid dependent patients treated with methadone, buprenorphine or implant naltrexone
    Kelty, Erin
    Hulse, Gary
    [J]. INTERNATIONAL JOURNAL OF DRUG POLICY, 2017, 46 : 54 - 60
  • [5] Slow-release naltrexone implant versus oral naltrexone for improving treatment outcomes in people with HIV who are addicted to opioids: a double-blind, placebo-controlled, randomised trial
    Krupitsky, Evgeny
    Blokhina, Elena
    Zvartau, Edwin
    Verbitskaya, Elena
    Lioznov, Dmitri
    Yaroslavtseva, Tatiana
    Palatkin, Vladimir
    Vetrova, Marina
    Bushara, Natalia
    Burakov, Andrei
    Masalov, Dmitri
    Mamontova, Olga
    Langleben, Daniel
    Poole, Sabrina
    Gross, Robert
    Woody, George
    [J]. LANCET HIV, 2019, 6 (04): : E221 - E229
  • [6] Randomized Trial of Long-Acting Sustained-Release Naltrexone Implant vs Oral Naltrexone or Placebo for Preventing Relapse to Opioid Dependence
    Krupitsky, Evgeny
    Zvartau, Edwin
    Blokhina, Elena
    Verbitskaya, Elena
    Wahlgren, Valentina
    Tsoy-Podosenin, Marina
    Bushara, Natalia
    Burakov, Andrey
    Masalov, Dmitry
    Romanova, Tatyana
    Tyurina, Arina
    Palatkin, Vladimir
    Slavina, Tatyana
    Pecoraro, Anna
    Woody, George E.
    [J]. ARCHIVES OF GENERAL PSYCHIATRY, 2012, 69 (09) : 973 - 981
  • [7] Injectable extended-release naltrexone for opioid dependence: a double-blind, placebo-controlled, multicentre randomised trial
    Krupitsky, Evgeny
    Nunes, Edward V.
    Ling, Walter
    Illeperuma, Ari
    Gastfriend, David R.
    Silverman, Bernard L.
    [J]. LANCET, 2011, 377 (9776) : 1506 - 1513
  • [8] Weekly and Monthly Subcutaneous Buprenorphine Depot Formulations vs Daily Sublingual Buprenorphine With Naloxone for Treatment of Opioid Use Disorder A Randomized Clinical Trial
    Lofwall, Michelle R.
    Walsh, Sharon L.
    Nunes, Edward V.
    Bailey, Genie L.
    Sigmon, Stacey C.
    Kampman, Kyle M.
    Frost, Michael
    Tiberg, Fredrik
    Linden, Margareta
    Sheldon, Behshad
    Oosman, Sonia
    Peterson, Stefan
    Chen, Michael
    Kim, Sonnie
    [J]. JAMA INTERNAL MEDICINE, 2018, 178 (06) : 764 - 773
  • [9] Impact of Opioid Substitution Therapy on Antiretroviral Therapy Outcomes: A Systematic Review and Meta-Analysis
    Low, Andrea J.
    Mburu, Gitau
    Welton, Nicky J.
    May, Margaret T.
    Davies, Charlotte F.
    French, Clare
    Turner, Katy M.
    Looker, Katharine J.
    Christensen, Hannah
    McLean, Susie
    Rhodes, Tim
    Platt, Lucy
    Hickman, Matthew
    Guise, Andy
    Vickerman, Peter
    [J]. CLINICAL INFECTIOUS DISEASES, 2016, 63 (08) : 1094 - 1104
  • [10] Mazhnaya A, 2018, JAIDS-J ACQ IMM DEF, V79, P288, DOI [10.1097/qai.0000000000001827, 10.1097/QAI.0000000000001827]
12